 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| HEC53856 / HEC Pharm
New P1 trial: HEC53856-RAD-102: HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia (clinicaltrials.gov) - Jun 14, 2021
P1, N=60, Not yet recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.
- ||| HEC53856 / HEC Pharm
New P1 trial: HEC53856-RAD-103: Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. (clinicaltrials.gov) - Jun 14, 2021
P1, N=60, Not yet recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.
- ||| HEC53856 / HEC Pharm
Trial completion: HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers (clinicaltrials.gov) - Mar 18, 2020
P1, N=116, Completed, Sponsor: Sunshine Lake Pharma Co., Ltd.
Recruiting --> Completed
- ||| HEC53856 / HEC Pharm
Enrollment open: HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers (clinicaltrials.gov) - May 20, 2019
P1, N=116, Recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||| HEC53856 / HEC Pharm
New P1 trial: HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers (clinicaltrials.gov) - Mar 22, 2019
P1, N=116, Not yet recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.